What is the price target for VMD stock?
6 analysts have analysed VMD and the average price target is 13.26 USD. This implies a price increase of 52.24% is expected in the next year compared to the current price of 8.71.
NASDAQ:VMD • CA92663R1055
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for VIEMED HEALTHCARE INC (VMD).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2021-11-03 | RBC Capital | Maintains | Outperform |
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | ||
|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 183.008M 31.85% | 224.257M 22.54% | 270.28M 20.52% | 318.6M 17.88% | 366.33M 14.98% | 420.16M 14.69% | |
| EBITDA YoY % growth | 36.837M 52.03% | 41.363M 12.29% | 49.323M 19.24% | 71.054M 44.06% | 79.285M 11.58% | N/A | |
| EBIT YoY % growth | 14.975M 74.13% | 15.995M 6.81% | 20.71M 29.48% | 31.007M 49.72% | 38.986M 25.73% | 53.025M 36.01% | |
| Operating Margin | 8.18% | 7.13% | 7.66% | 9.73% | 10.64% | 12.62% | |
| EPS YoY % growth | 0.26 73.33% | 0.28 7.69% | 0.37 32.14% | 0.47 28.30% | 0.63 31.91% | N/A |
All data in USD
| Q1 / 26 | Q2 / 26 | Q3 / 26 | |
|---|---|---|---|
| EPS Q2Q % growth | 0.10 68.33% | 0.12 51.50% | 0.12 34.67% |
| Revenue Q2Q % growth | 76.407M 29.22% | 82.669M 31.10% | 85.85M 19.38% |
| EBITDA Q2Q % growth | 16.211M 100.48% | 17.877M -0.48% | 18.13M -33.25% |
| EBIT Q2Q % growth | 6.363M 331.98% | 7.777M 74.41% | 7.929M 29.60% |
All data in USD
6 analysts have analysed VMD and the average price target is 13.26 USD. This implies a price increase of 52.24% is expected in the next year compared to the current price of 8.71.
VIEMED HEALTHCARE INC (VMD) will report earnings on 2026-05-05.
The consensus EPS estimate for the next earnings of VIEMED HEALTHCARE INC (VMD) is 0.1 USD and the consensus revenue estimate is 76.41M USD.
The number of analysts covering VIEMED HEALTHCARE INC (VMD) is 6.